Ameriprise Financial Inc T2 Biosystems, Inc. Transaction History

Ameriprise Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.15 - $0.54 $3,000 - $10,803	-20,006 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.36 - $0.57 $1,584 - $2,508	-4,400 Reduced 18.03%	20,006 $10,000
Q4 2021 Feb 14, 2022	SELL	$0.46 - $0.94 $74,895 - $153,047	-162,817 Reduced 86.96%	24,406 $13,000
Q3 2021 Nov 15, 2021	SELL	$0.86 - $1.21 $15,032 - $21,150	-17,480 Reduced 8.54%	187,223 $171,000
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.69 $10,734 - $17,444	-10,322 Reduced 4.8%	204,703 $244,000
Q1 2021 May 17, 2021	SELL	$1.32 - $3.79 $104,957 - $301,354	-79,513 Reduced 27.0%	215,025 $348,000
Q4 2020 Feb 12, 2021	SELL	$1.06 - $1.51 $50,422 - $71,827	-47,568 Reduced 13.9%	294,538 $365,000
Q3 2020 Nov 16, 2020	BUY	$1.15 - $2.1 $198,197 - $361,926	172,346 Added 101.52%	342,106 $465,000
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.67 $81,484 - $283,499	169,760 New	169,760 $216,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.